Post-TB health and wellbeing

Becky Nightingale; F. Carlin; Jamilah Meghji; K. McMullen; D. Evans; M. M. van der Zalm; M. G. Anthony; M. Bittencourt; A. Byrne; K. du Preez; M. Coetzee; C. Feris; P. Goussard; K. Hirasen; J. Bouwer; G. Hoddinott; M. A. Huaman; G. Inglis-Jassiem; O. Ivanova; F. Karmadwala; H. S. Schaaf; I. Schoeman; J. A. Seddon; T. Sineke; R. Solomons; M. Thiart; R. van Toorn; P. I. Fujiwara; K. Romanowski; S. Marais; A. C. Hesseling; J. Johnston; B. Allwood; Chakaya Muhwa; Kevin Mortimer

doi:10.5588/ijtld.22.0514

Post-TB health and wellbeing

Becky Nightingale, F. Carlin, Jamilah Meghji, K. McMullen, D. Evans, M. M. van der Zalm, M. G. Anthony, M. Bittencourt, A. Byrne, K. du Preez, M. Coetzee, C. Feris, P. Goussard, K. Hirasen, J. Bouwer, G. Hoddinott, M. A. Huaman, G. Inglis-Jassiem, O. Ivanova, F. KarmadwalaH. S. Schaaf, I. Schoeman, J. A. Seddon, T. Sineke, R. Solomons, M. Thiart, R. van Toorn, P. I. Fujiwara, K. Romanowski, S. Marais, A. C. Hesseling, J. Johnston, B. Allwood, Chakaya Muhwa, Kevin Mortimer

Research output: Contribution to journal › Article › peer-review

98 Citations (Scopus)

Abstract

TB affects around 10.6 million people each year and there are now around 155 million TB survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In 2019, representatives of TB affected communities attending the ‘1st International Post-Tuberculosis Symposium´ called for the development of clinical guidance on these issues. This clinical statement on post-TB health and wellbeing responds to this call and builds on the work of the symposium, which brought together TB survivors, healthcare professionals and researchers. Our document offers expert opinion and, where possible, evidence-based guidance to aid clinicians in the diagnosis and management of post-TB conditions and research in this field. It covers all aspects of post-TB, including economic, social and psychological wellbeing, post TB lung disease (PTLD), cardiovascular and pericardial disease, neurological disability, effects in adolescents and children, and future research needs.

Original language	English
Pages (from-to)	248-283
Number of pages	36
Journal	International Journal of Tuberculosis and Lung Disease
Volume	27
Issue number	4
DOIs	https://doi.org/10.5588/ijtld.22.0514
Publication status	Published - 1 Apr 2023

Keywords

post-TB socio-economic burden
post-tuberculosis lung disease
quality of life
tuberculous neuropathy
tuberculous pericarditis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5588/ijtld.22.0514Licence: CC BY

Post-TB health and wellbeingFinal published version, 3.73 MBLicence: CC BY

Cite this

Nightingale, B., Carlin, F., Meghji, J., McMullen, K., Evans, D., van der Zalm, M. M., Anthony, M. G., Bittencourt, M., Byrne, A., du Preez, K., Coetzee, M., Feris, C., Goussard, P., Hirasen, K., Bouwer, J., Hoddinott, G., Huaman, M. A., Inglis-Jassiem, G., Ivanova, O., ... Mortimer, K. (2023). Post-TB health and wellbeing. International Journal of Tuberculosis and Lung Disease, 27(4), 248-283. https://doi.org/10.5588/ijtld.22.0514

@article{4599325f8410496ea5d4ffde9d36dd1b,

title = "Post-TB health and wellbeing",

abstract = "TB affects around 10.6 million people each year and there are now around 155 million TB survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In 2019, representatives of TB affected communities attending the {\textquoteleft}1st International Post-Tuberculosis Symposium´ called for the development of clinical guidance on these issues. This clinical statement on post-TB health and wellbeing responds to this call and builds on the work of the symposium, which brought together TB survivors, healthcare professionals and researchers. Our document offers expert opinion and, where possible, evidence-based guidance to aid clinicians in the diagnosis and management of post-TB conditions and research in this field. It covers all aspects of post-TB, including economic, social and psychological wellbeing, post TB lung disease (PTLD), cardiovascular and pericardial disease, neurological disability, effects in adolescents and children, and future research needs.",

keywords = "post-TB socio-economic burden, post-tuberculosis lung disease, quality of life, tuberculous neuropathy, tuberculous pericarditis",

author = "Becky Nightingale and F. Carlin and Jamilah Meghji and K. McMullen and D. Evans and \{van der Zalm\}, \{M. M.\} and Anthony, \{M. G.\} and M. Bittencourt and A. Byrne and \{du Preez\}, K. and M. Coetzee and C. Feris and P. Goussard and K. Hirasen and J. Bouwer and G. Hoddinott and Huaman, \{M. A.\} and G. Inglis-Jassiem and O. Ivanova and F. Karmadwala and Schaaf, \{H. S.\} and I. Schoeman and Seddon, \{J. A.\} and T. Sineke and R. Solomons and M. Thiart and \{van Toorn\}, R. and Fujiwara, \{P. I.\} and K. Romanowski and S. Marais and Hesseling, \{A. C.\} and J. Johnston and B. Allwood and Chakaya Muhwa and Kevin Mortimer",

year = "2023",

month = apr,

day = "1",

doi = "10.5588/ijtld.22.0514",

language = "English",

volume = "27",

pages = "248--283",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union Against Tuberculosis and Lung Disease ",

number = "4",

}

Nightingale, B, Carlin, F, Meghji, J, McMullen, K, Evans, D, van der Zalm, MM, Anthony, MG, Bittencourt, M, Byrne, A, du Preez, K, Coetzee, M, Feris, C, Goussard, P, Hirasen, K, Bouwer, J, Hoddinott, G, Huaman, MA, Inglis-Jassiem, G, Ivanova, O, Karmadwala, F, Schaaf, HS, Schoeman, I, Seddon, JA, Sineke, T, Solomons, R, Thiart, M, van Toorn, R, Fujiwara, PI, Romanowski, K, Marais, S, Hesseling, AC, Johnston, J, Allwood, B, Muhwa, C & Mortimer, K 2023, 'Post-TB health and wellbeing', International Journal of Tuberculosis and Lung Disease, vol. 27, no. 4, pp. 248-283. https://doi.org/10.5588/ijtld.22.0514

TY - JOUR

T1 - Post-TB health and wellbeing

AU - Nightingale, Becky

AU - Carlin, F.

AU - Meghji, Jamilah

AU - McMullen, K.

AU - Evans, D.

AU - van der Zalm, M. M.

AU - Anthony, M. G.

AU - Bittencourt, M.

AU - Byrne, A.

AU - du Preez, K.

AU - Coetzee, M.

AU - Feris, C.

AU - Goussard, P.

AU - Hirasen, K.

AU - Bouwer, J.

AU - Hoddinott, G.

AU - Huaman, M. A.

AU - Inglis-Jassiem, G.

AU - Ivanova, O.

AU - Karmadwala, F.

AU - Schaaf, H. S.

AU - Schoeman, I.

AU - Seddon, J. A.

AU - Sineke, T.

AU - Solomons, R.

AU - Thiart, M.

AU - van Toorn, R.

AU - Fujiwara, P. I.

AU - Romanowski, K.

AU - Marais, S.

AU - Hesseling, A. C.

AU - Johnston, J.

AU - Allwood, B.

AU - Muhwa, Chakaya

AU - Mortimer, Kevin

PY - 2023/4/1

Y1 - 2023/4/1

N2 - TB affects around 10.6 million people each year and there are now around 155 million TB survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In 2019, representatives of TB affected communities attending the ‘1st International Post-Tuberculosis Symposium´ called for the development of clinical guidance on these issues. This clinical statement on post-TB health and wellbeing responds to this call and builds on the work of the symposium, which brought together TB survivors, healthcare professionals and researchers. Our document offers expert opinion and, where possible, evidence-based guidance to aid clinicians in the diagnosis and management of post-TB conditions and research in this field. It covers all aspects of post-TB, including economic, social and psychological wellbeing, post TB lung disease (PTLD), cardiovascular and pericardial disease, neurological disability, effects in adolescents and children, and future research needs.

AB - TB affects around 10.6 million people each year and there are now around 155 million TB survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In 2019, representatives of TB affected communities attending the ‘1st International Post-Tuberculosis Symposium´ called for the development of clinical guidance on these issues. This clinical statement on post-TB health and wellbeing responds to this call and builds on the work of the symposium, which brought together TB survivors, healthcare professionals and researchers. Our document offers expert opinion and, where possible, evidence-based guidance to aid clinicians in the diagnosis and management of post-TB conditions and research in this field. It covers all aspects of post-TB, including economic, social and psychological wellbeing, post TB lung disease (PTLD), cardiovascular and pericardial disease, neurological disability, effects in adolescents and children, and future research needs.

KW - post-TB socio-economic burden

KW - post-tuberculosis lung disease

KW - quality of life

KW - tuberculous neuropathy

KW - tuberculous pericarditis

U2 - 10.5588/ijtld.22.0514

DO - 10.5588/ijtld.22.0514

M3 - Article

SN - 1027-3719

VL - 27

SP - 248

EP - 283

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 4

ER -

Post-TB health and wellbeing

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this